HK1019404A1 - Injection formulations of avermectins or milbemycins based on castor oil, their preparation, and use of castor for preparing the same - Google Patents
Injection formulations of avermectins or milbemycins based on castor oil, their preparation, and use of castor for preparing the sameInfo
- Publication number
- HK1019404A1 HK1019404A1 HK99104544A HK99104544A HK1019404A1 HK 1019404 A1 HK1019404 A1 HK 1019404A1 HK 99104544 A HK99104544 A HK 99104544A HK 99104544 A HK99104544 A HK 99104544A HK 1019404 A1 HK1019404 A1 HK 1019404A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- castor
- avermectins
- preparing
- preparation
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19613972A DE19613972A1 (de) | 1996-04-09 | 1996-04-09 | Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl |
PCT/EP1997/001569 WO1997037653A1 (fr) | 1996-04-09 | 1997-03-27 | Formulations a injecter d'avermectines et de milbemycines a base d'huile de ricin |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1019404A1 true HK1019404A1 (en) | 2000-02-11 |
Family
ID=7790774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK99104544A HK1019404A1 (en) | 1996-04-09 | 1999-10-14 | Injection formulations of avermectins or milbemycins based on castor oil, their preparation, and use of castor for preparing the same |
Country Status (14)
Country | Link |
---|---|
US (1) | US6063394A (fr) |
EP (1) | EP0896534B1 (fr) |
JP (1) | JP4257870B2 (fr) |
CN (1) | CN1095662C (fr) |
AT (1) | ATE285233T1 (fr) |
AU (1) | AU718807B2 (fr) |
BR (1) | BR9708540B1 (fr) |
CA (1) | CA2251087C (fr) |
DE (2) | DE19613972A1 (fr) |
ES (1) | ES2235230T3 (fr) |
HK (1) | HK1019404A1 (fr) |
NZ (1) | NZ332224A (fr) |
PT (1) | PT896534E (fr) |
WO (1) | WO1997037653A1 (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19638045A1 (de) * | 1996-09-18 | 1998-03-19 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen |
BR9815352A (pt) * | 1997-12-03 | 2000-10-17 | Merck & Co Inc | "formulação injetável de longa ação, e, processos para a prevenção ou tratamento de infestação parasìtica em um hospedeiro em necessidade dele, para tratamento ou prevenção de infestação por insetos por um perìodo prolongado de tempo em um hospedeiro em necessidade dele, para promover crescimento em animais, e para tratar inflamação, dor ou febre por um perìodo estendido de tempo em um hospedeiro em necessidade. " |
US6174540B1 (en) | 1998-09-14 | 2001-01-16 | Merck & Co., Inc. | Long acting injectable formulations containing hydrogenated caster oil |
GB9827727D0 (en) * | 1998-12-16 | 1999-02-10 | Pfizer Ltd | Antiparasitic formulations |
GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
AU781682B2 (en) * | 2000-03-20 | 2005-06-09 | Zoetis Services Llc | Sustained-release compositions for parenteral administration |
US20050009762A1 (en) * | 2003-06-06 | 2005-01-13 | Strobel Michael Albert | Application of water and organic solvent soluble ivermectin for topical and oral use |
CN1275589C (zh) * | 2002-05-31 | 2006-09-20 | 王玉万 | 含抗寄生虫药物的缓释注射剂 |
US7262214B2 (en) | 2003-02-26 | 2007-08-28 | Merial Limited | 1-N-arylpyrazole derivatives in prevention of arthropod-borne and mosquito-borne diseases |
US20050271459A1 (en) * | 2004-06-03 | 2005-12-08 | World Wide Stationery Mfg. Co., Ltd. | Interlocking ring tip formations for paired ring members of a ring binder mechanism |
NZ534939A (en) * | 2004-08-26 | 2007-04-27 | Bomac Research Ltd | Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility |
DE102004053964A1 (de) * | 2004-11-09 | 2006-05-11 | Bayer Healthcare Ag | Mittel gegen Demodikose |
EP2194965B1 (fr) * | 2007-08-31 | 2016-07-20 | Archimedes Development Limited | Compositions pharmaceutiques non aqueuses |
NZ590141A (en) * | 2008-06-24 | 2012-05-25 | Merial Ltd | Anthelminthic formulations including castor oil and another vegetable oil |
PL2396006T3 (pl) | 2009-02-16 | 2013-06-28 | Zoetis Llc | Preparat zawierający doramektynę w dużej dawce |
CN101773467B (zh) * | 2010-01-20 | 2015-09-09 | 北京大北农动物保健科技有限责任公司 | 一种美贝霉素或美贝霉素肟的兽用缓释注射液及制备方法 |
KR101805087B1 (ko) * | 2010-09-16 | 2017-12-05 | 주식회사 엘지화학 | 높은 방부력을 제공하는 오일 주사 제형 |
AU2013201479C1 (en) * | 2012-03-13 | 2017-11-09 | Elanco New Zealand | Long Acting Compositions |
RU2020122841A (ru) | 2017-12-15 | 2022-01-18 | Тарсус Фармасьютикалс, Инк. | Изоксазолиновые паразитицидные составы и способы лечения блефарита |
US11077134B1 (en) | 2020-11-10 | 2021-08-03 | Mountain Valley Md Inc | Water dissolvable macrocyclic lactone cyclodextrin complexes |
US11638714B2 (en) | 2020-11-10 | 2023-05-02 | Mountain Valley Md Inc | Water dissolvable macrocyclic lactone cyclodextrin complexes |
CN114642632A (zh) * | 2022-02-25 | 2022-06-21 | 河北科技大学 | 一种莫西克汀注射液及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4914624A (fr) * | 1972-06-08 | 1974-02-08 | ||
SE434277B (sv) * | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
US4199569A (en) * | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
OA06863A (fr) * | 1980-08-04 | 1983-02-28 | Merck & Co Inc | Solubilisation de l'invermectine dans l'eau. |
NZ210505A (en) * | 1983-12-22 | 1988-06-30 | Merck & Co Inc | Parasiticidal compositions containing avermectin or milbemycin derivatives |
DE3727648A1 (de) * | 1987-08-19 | 1989-03-02 | Bayer Ag | Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung |
US5510117A (en) * | 1989-03-09 | 1996-04-23 | Micro-Pak, Inc. | Entrapment vehicle and method |
ES2052173T3 (es) * | 1989-04-11 | 1994-07-01 | Pfizer | Composiciones inyectables que contienen 25-cyclohexil-avermectina b1. |
NZ234802A (en) * | 1989-08-14 | 1992-11-25 | Merck & Co Inc | Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals |
ES2086022T3 (es) * | 1991-07-23 | 1996-06-16 | American Cyanamid Co | Composiciones estables para administracion parenteral y su uso. |
ATE180671T1 (de) * | 1991-09-30 | 1999-06-15 | Merck & Co Inc | Hydrierte rizinusöl-enthaltende injizierbare formulierungen mit verlängerter wirkstoffabgabe |
AU5330294A (en) * | 1992-10-21 | 1994-05-09 | Micro Vesicular Systems, Inc. | Entrapment vehicle and method |
-
1996
- 1996-04-09 DE DE19613972A patent/DE19613972A1/de not_active Withdrawn
-
1997
- 1997-03-27 CN CN97193700A patent/CN1095662C/zh not_active Expired - Lifetime
- 1997-03-27 US US09/155,836 patent/US6063394A/en not_active Expired - Lifetime
- 1997-03-27 WO PCT/EP1997/001569 patent/WO1997037653A1/fr active IP Right Grant
- 1997-03-27 BR BRPI9708540-5A patent/BR9708540B1/pt active IP Right Grant
- 1997-03-27 CA CA002251087A patent/CA2251087C/fr not_active Expired - Lifetime
- 1997-03-27 JP JP53579597A patent/JP4257870B2/ja not_active Expired - Fee Related
- 1997-03-27 AU AU25066/97A patent/AU718807B2/en not_active Expired
- 1997-03-27 AT AT97916406T patent/ATE285233T1/de active
- 1997-03-27 NZ NZ332224A patent/NZ332224A/en not_active IP Right Cessation
- 1997-03-27 ES ES97916406T patent/ES2235230T3/es not_active Expired - Lifetime
- 1997-03-27 EP EP97916406A patent/EP0896534B1/fr not_active Expired - Lifetime
- 1997-03-27 PT PT97916406T patent/PT896534E/pt unknown
- 1997-03-27 DE DE59712134T patent/DE59712134D1/de not_active Expired - Lifetime
-
1999
- 1999-10-14 HK HK99104544A patent/HK1019404A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0896534A1 (fr) | 1999-02-17 |
BR9708540B1 (pt) | 2010-07-27 |
CA2251087A1 (fr) | 1997-10-16 |
WO1997037653A1 (fr) | 1997-10-16 |
JP2000508301A (ja) | 2000-07-04 |
DE59712134D1 (de) | 2005-01-27 |
BR9708540A (pt) | 1999-08-03 |
CN1095662C (zh) | 2002-12-11 |
ES2235230T3 (es) | 2005-07-01 |
CA2251087C (fr) | 2008-01-15 |
ATE285233T1 (de) | 2005-01-15 |
CN1215331A (zh) | 1999-04-28 |
NZ332224A (en) | 2000-06-23 |
AU2506697A (en) | 1997-10-29 |
PT896534E (pt) | 2005-04-29 |
US6063394A (en) | 2000-05-16 |
JP4257870B2 (ja) | 2009-04-22 |
AU718807B2 (en) | 2000-04-20 |
DE19613972A1 (de) | 1997-10-16 |
EP0896534B1 (fr) | 2004-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1019404A1 (en) | Injection formulations of avermectins or milbemycins based on castor oil, their preparation, and use of castor for preparing the same | |
AU4308397A (en) | Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors | |
AU3897197A (en) | Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents | |
GR3036548T3 (en) | Apparatus and method for preparing solid forms with controlled release of the active ingredient | |
AU6564794A (en) | Use of nona- and decapeptides in the preparation of a drug for the treatment of aids | |
AU5833994A (en) | Pharmaceutical and dermocosmetic compositions containing equine colostrum | |
BG103384A (en) | Halogenpyrimidinylaryl (thio)ethers as pesticides | |
ZA978352B (en) | Injection formulations of avermectins and milbemycins. | |
AU5648496A (en) | Pyrazolo-(1,5a)pyrimidines, their preparation and their use | |
IL122737A0 (en) | Salts of amidine derivative and cyclooxygenase inhibitors their preparation and pharmaceutical compositions containing them | |
GB2288183B (en) | Composition and method of preparing microemulsion blends | |
AU5892399A (en) | 1, 2, 4-triazole-3-thione compounds | |
AU3066697A (en) | 8-hydrocarbyl substituted benzodizocine derivatives, their preparation and the ir use as protein kinase c (=pkc) modulators | |
ZA989664B (en) | 3-substituted tetrahydropyrimidinone derivatives, their preparation and use. | |
MY127474A (en) | Naphthyl compounds, intermediates, compositions, and methods of use | |
HK1002658A1 (en) | Imidazopyridine-azolidinones their preparation and pharmaceutical use | |
UA48245C2 (uk) | ЗАМІЩЕНІ 1,2,3,4-ТЕТРАГІДРО-2-ДИБЕНЗОФУРАНАМІНИ ТА 2-АМІНОЦИКЛОГЕПТА[B]БЕНЗОФУРАНИ, ФАРМАЦЕВТИЧНА ЛІКАРСЬКА ФОРМА ТА СПОСІБ ПІДВИЩЕННЯ АКТИВАЦІЇ 5-НТ<sub>1F</sub> РЕЦЕПТОРА У ССАВЦЯ | |
CA2151123A1 (fr) | Cellules modifiees au niveau du catabolisme de la betaine, preparation et utilisations, notamment pour la production de metabolites ou d'enzymes | |
ZA976619B (en) | Benzimidazole derivatives, their preparation and their therapeutic applications. | |
ZA989571B (en) | 2-Substituted 1,2-Benzoisonthiazole derivatives, their preparation and use. | |
AU6646094A (en) | New pyridinium salts and their use for controlling helicobacter bacteria | |
HK1036070A1 (en) | 5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them. | |
AP2000001746A0 (en) | Anti- first-pass effect compounds. | |
AU2025997A (en) | Novel heterocyclically substituted imidazoloquinoxalinones, their preparation and their use | |
AU5870298A (en) | 1,4-dihydropyridin derivatives and their use in therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20170326 |